Evidence map›Paper›PMID 36500242›Full record

ArticleMolecules (Basel, Switzerland)2022

Marta Modrzewska, Lidia Błaszczyk, Łukasz Stępień, Monika Urbaniak, Agnieszka Waśkiewicz, Tomoya Yoshinari, Marcin Bryła

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Pathogenicity and Toxigenic Chemotype Analysis ofJournal of fungi (Basel, Switzerland) · 2026
    Article
  2. Journal of fungi (Basel, Switzerland) · 2026
    Article
  3. Article
  4. EndophyticFrontiers in microbiology · 2026
    Article
  5. Article
  6. Article
  7. Interaction ofJournal of fungi (Basel, Switzerland) · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Containment ofJournal of fungi (Basel, Switzerland) · 2023
    Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marta ModrzewskaDepartment of Food Safety and Chemical Analysis, Waclaw Dabrowski Institute of Agricultural and Food Biotechnology-State Research Institute, Rakowiecka 36, 02-532 Warsaw, Poland.ORCID 0000-0003-4534-3552
Lidia BłaszczykPlant Microbiomics Team, Institute of Plant Genetics, Polish Academy of Sciences, 60-479 Poznan, Poland.
Łukasz StępieńPlant-Pathogen Interaction Team, Institute of Plant Genetics, Polish Academy of Sciences, 60-479 Poznan, Poland.ORCID 0000-0001-9740-9520
Monika UrbaniakPlant-Pathogen Interaction Team, Institute of Plant Genetics, Polish Academy of Sciences, 60-479 Poznan, Poland.ORCID 0000-0002-1735-4556
Agnieszka WaśkiewiczDepartment of Chemistry, Poznan University of Life Sciences, Wojska Polskiego 75, 60-625 Poznan, Poland.ORCID 0000-0003-4113-1595
Tomoya YoshinariDivision of Microbiology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki-shi 210-9501, Kanagawa, Japan.
Marcin BryłaDepartment of Food Safety and Chemical Analysis, Waclaw Dabrowski Institute of Agricultural and Food Biotechnology-State Research Institute, Rakowiecka 36, 02-532 Warsaw, Poland.ORCID 0000-0002-1855-3610

Funding

National Science Center 2019/33/B/NZ9/02743
6 · The paper itself

Abstract

This study evaluated the ability of selected strains of

Indexed as

FusariumMycotoxinsOryzaTrichodermaTrichothecenesZearalenoneMycotoxinsnivalenolTrichothecenesZearalenoneFusarium spp.mycotoxinsplant biocontrolTrichoderma spp.

Identifiers

PMID36500242
PMCPMC9735881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.